High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/8/1359/318621/mdi248.pdf
Reference33 articles.
1. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's Lymphoma;Fisher;N Engl J Med,1993
2. EBMT Workshop: High dose therapy in aggressive NHL;Schmitz;Ann Hematol,2001
3. Randomised study to evaluate the use of high-dose therapy as part of primary treatment for ‘aggressive’ lymphoma;Kaiser;J Clin Oncol,2002
4. Randomised comparison of CHOEP versus CHOEP/IVEP for high-grade non-Hodgkin's lymphoma: Treatment results and prognostic factor analysis in a multi-center trial;Koeppler;Ann Oncol,1994
5. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-a group d'Etude des lymphomes de l'Adulte study;Haioun;J Clin Oncol,2000
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of positron emission tomography in different types of malignant lymphomas: the results of 2020;Journal of Modern Oncology;2021-05-19
2. Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience;Clinical Lymphoma Myeloma and Leukemia;2021-02
3. Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma;Medicine;2020-12-04
4. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity;Clinical Lymphoma Myeloma and Leukemia;2020-10
5. Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas;Journal of Cancer Research and Clinical Oncology;2019-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3